'Nanobodies' could hold clues to new COVID-19 therapies

WEHI researchers are studying ‘nanobodies’ – tiny immune proteins made by alpacas—in a bid to understand whether they might be effective in blocking SARS-CoV-2, the virus that causes COVID-19.


Click here for original story, ‘Nanobodies’ could hold clues to new COVID-19 therapies


Source: Phys.org